中医墨宝联合阿昔洛韦治疗带状疱疹的临床效果

Clinical effect of Mobao recipe of traditional Chinese medicine combined with acyclovir on the treatment of herpes zoster

  • 摘要:
      目的  探讨中医墨宝联合阿昔洛韦治疗带状疱疹的临床效果。
      方法  选择94例带状疱疹患者以随机数表法分为对照组、研究组,各47例。对照组采用阿昔洛韦治疗,研究组在此基础上联合中医墨宝治疗。评价2组带状疱疹患者的临床疗效,水疱消退时间、完全脱痂时间与止痛时间,治疗前与治疗7 d时视觉模拟评分(VAS)的变化,治疗期间的不良反应情况。
      结果  研究组治疗总有效率为95.7%,显著高于对照组的78.7%(P < 0.05); 研究组患者水疱消退时间、完全脱痂时间与止痛时间均显著早于对照组(P < 0.05); 研究组患者治疗7 d时的VAS量表评分显著低于对照组(P < 0.05); 研究组患者治疗期间的不良反应发生率为6.4%, 与对照组的6.4%无显著差异(P>0.05)。
      结论  中医墨宝联合阿昔洛韦治疗带状疱疹能够进一步提高临床疗效,加快康复速度,改善疼痛症状,安全可靠。

     

    Abstract:
      Objective  To explore the clinical effect of Mobao recipe of traditional Chinese medicine combined with acyclovir in the treatment of herpes zoster.
      Methods  A total of 94 patients with herpes zoster admitted to our hospital were selected as study subjects, and were divided into two groups by random number table method. The control group(n=47) was treated with acyclovir alone and the study group(n=47) was additionally treated with Mobao recipe. The clinical efficacy, blister subsidence time, complete escharectomy time and pain relief time, Visual Analogue Scale (VAS) score before and 7 days after treatment, and adverse reactions during treatment of herpes zoster in the two groups were evaluated.
      Results  The total response rate of the study group was higher than that in the control group (95.7% vs. 78.7%, P < 0.05). The blister subsidence time, scab removal time and pain relief time of the study group were shorter than those in the control group(P < 0.05). The VAS scores of patients in the study group was lower than those of the control group on the 7th day after treatment (P < 0.05). There was no significant difference in the incidence of adverse reactions between the study group and the control group (6.4% vs. 6.4%, P>0.05).
      Conclusion  Mobao recipe combined with acyclovir in the treatment of herpes zoster can further improve the clinical efficacy, speed up recovery, and improve pain symptomsm, which is safe and reliable, and worthy of clinical promotion.

     

/

返回文章
返回